Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074172 · ClinicalTrials.gov registry record · Phase 2
The Effect of Cannabidiol in Learning and Memory of Adults
A Phase 2 study, sponsored by Colorado State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
NCT06074172 is a Phase 2 study that has completed, run by Colorado State University. The registered enrollment target is 57 participants.
The verdict
NCT06074172, a Phase 2 study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
Study Summary
The main objectives of this study were to test if a singular dose of Cannabidiol (1) enhances the learning and memory of healthy human subjects, (2) test if Cannabidiol has negative effects on Retroactive and Proactive Interference during learning, (3) and test if demographic factors will influence CBD's modulation of human learning and memory.
Interventions
- DRUG Cannabidiol (246mg press pill)
- DRUG Placebo (246mg press pill)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2020-03-14 |
| Est. Completion | 2020-11-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06074172
The ClinicalTrials.gov registry entry for NCT06074172 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cannabidiol (246mg press pill) is the first listed.
NCT06074172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06074172 about?
NCT06074172 is a clinical study titled "The Effect of Cannabidiol in Learning and Memory of Adults". The main objectives of this study were to test if a singular dose of Cannabidiol (1) enhances the learning and memory of healthy human subjects, (2) test if Cannabidiol has negative effects on Retroactive and Proactive Interference during learning, (3) and test if demographic factors will influence ...
What is the current status of trial NCT06074172?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2020-03-14. Estimated completion is 2020-11-06.
What interventions are being tested in trial NCT06074172?
The interventions under investigation include: Cannabidiol (246mg press pill) (DRUG), Placebo (246mg press pill) (DRUG).
Who is sponsoring clinical trial NCT06074172?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.